MINJUVI® (tafasitamab) for Relapsed or Refractory Follicular Lymphoma Approved in Australia Minjuvi® (tafasitamab), in combination with rituximab and lenalidomide, is the first and… CISION PRNewswireApril 23, 2026
Vantage Introduces an Enhanced App with a Seamless All-in-One Trading Experience PORT VILA, Vanuatu, April 23, 2026 /PRNewswire/ — Vantage, a multi-asset CFD platform,… CISION PRNewswireApril 23, 2026
Press ReleaseDragonpass Empowers Financial Institutions with End-to-End Loyalty Solutions at Money20/20 Asia BANGKOK, April 23, 2026 /PRNewswire/ — Dragonpass, a leading global travel and… CISION PRNewswireApril 23, 2026
WuXi Biologics Receives South Korea MFDS GMP Certification to Enable Commercial Manufacturing of Bispecific Antibody Therapeutics WUXI, China, April 23, 2026 /PRNewswire/ — WuXi Biologics (2269.HK), a leading global… CISION PRNewswireApril 23, 2026
BankingPress ReleaseTrinasolar Introduces Vertex N G3 Module to South Korea, Supporting High-Efficiency and Bankable Solar Deployment SEOUL, South Korea, April 23, 2026 /PRNewswire/ — Trinasolar, a global leader… CISION PRNewswireApril 23, 2026
Press ReleaseTech. For Family: CHERY VPD World Premiere Concludes, Ushering in a Warm Era of Intelligent Parking BEIJING, April 23, 2026 /PRNewswire/ — On April 22, CHERY VPD made… CISION PRNewswireApril 23, 2026
Finloop Launches "RWA CONNECT 2026" to Build a Global Open-Source RWA Ecosystem HONG KONG, April 23, 2026 /PRNewswire/ — At the "Connecting the World:… CISION PRNewswireApril 23, 2026
Press ReleaseX Square Robot Unveils New Embodied AI Model, Says Robots Will Arrive in Homes in 35 Days Backed by Alibaba, ByteDance, Xiaomi and Meituan, X Square Robot unveiled a… CISION PRNewswireApril 23, 2026
